Author
Bindng
Racing to a Cure: A Cancer Victim Refuses Chemotherapy and Finds Tomorrows Cures in Todays Scientific Laboratories
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Payment Option
In 1998 Neil Ruzic was diagnosed with mantlecell lymphoma, the deadliest cancer of the lymph system. Unhappy with the success rates of standard chemotherapy and radiation treatments, Ruzic took control of his destiny and began to investigate the cuttingedge cures being developed in research laboratories. Going on the offensive, Ruzic visited scores of laboratories, talked to researchers, gathered information, and effectively became his own patientcare advocate. Racing to a Cure provides a scathing critique of the chemotherapy culture as well as of unscientific alternative therapies and endorses stateoftheart, molecularly based technologies, making it an illuminating and necessary read for anyone interested in cancer research, especially patients and their families and physicians. Although expected to die within two years of his initial diagnosis, Neil Ruzic survived for more than five years before the cancer returned and claimed his life in January 2004. David Ruzic has added new material to this edition to explain the most recent cancer therapies for Mantle Cell Lymphoma as well as celebrate his fathers achievements in extending his life, exploding myths about cancer, and setting precedents for patients wanting more from their treatment.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.